9 results match your criteria: "Germany. Heidelberg Institute for Radiation Oncology (HIRO)[Affiliation]"
Phys Med Biol
October 2020
Department of Dosimetry for Radiation Therapy and Diagnostic Radiology, Physikalisch-Technische Bundesanstalt (PTB), Bundesallee 100, D-38116 Braunschweig, Germany. Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany. Department of Physics and Astronomy, University of Heidelberg, Im Neuenheimer Feld 226, D-69120 Heidelberg, Germany.
Ionization chamber-based dosimetry for carbon-ion beams still shows a significantly higher standard uncertainty than high-energy photon dosimetry. This is mainly caused by the high standard uncertainty of the correction factor for beam quality [Formula: see text]. Due to a lack of experimental data, the given values for [Formula: see text] are based on theoretical calculations.
View Article and Find Full Text PDFPhys Med Biol
September 2019
Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Faculty of Physics and Astronomy, Heidelberg University, Heidelberg, Germany. Heidelberg Institute for Radiation Oncology (HIRO), National Center for Research in Radiation Oncology (NCRO), Heidelberg, Germany. Author to whom any correspondence should be addressed.
The dose conformation and the sparing of neighboring critical healthy structures are improved in carbon-ion beam radiotherapy in comparison to conventional photon radiotherapy. Inter and intrafractional plan adaptation strategies may preclude the quality assurance (QA) of the actually applied treatment plan before the treatment starts. Therefore, independent measurements of the positions of scanned pencil C ion beams are of interest in order to monitor the beam application during the treatment and the beam in the isocenter.
View Article and Find Full Text PDFPhys Med Biol
March 2019
Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology, Heidelberg, Germany. Faculty of Physics and Astronomy, Heidelberg University, Heidelberg, Germany. Present address: European Organization for Nuclear Research CERN, Geneva, Switzerland. Author to whom any correspondence should be addressed.
Carbon ion radiotherapy is an attractive alternative to conventional radiotherapy, especially in case of deep-seated and radio-resistant tumors. As a consequence of inelastic nuclear reactions between primary particles and patient's tissues, the primary carbon ions may undergo nuclear fragmentation. The resulting decrease of primary ions and production of secondary fragments have to be carefully considered for accurate dose calculations in the treatment planning systems.
View Article and Find Full Text PDFPhys Med Biol
February 2018
Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany. Department of Physics and Astronomy, Heidelberg University, Heidelberg, Germany.
Ion-beam radiography (iRad) could potentially improve the quality control of ion-beam therapy. The main advantage of iRad is the possibility to directly measure the integrated stopping power. Until now there is no clinical implementation of iRad.
View Article and Find Full Text PDFPhys Med Biol
November 2017
Department of Medical Physics in Radiation Oncology, German Cancer Research Center-DKFZ, Im NeuenheimerFeld 280, D-69120 Heidelberg, Germany. Heidelberg Institute for Radiation Oncology-HIRO, Im Neuenheimer Feld 280, D-69120, Germany.
Particle therapy is especially prone to uncertainties. This issue is usually addressed with uncertainty quantification and minimization techniques based on scenario sampling. For proton therapy, however, it was recently shown that it is also possible to use closed-form computations based on analytical probabilistic modeling (APM) for this purpose.
View Article and Find Full Text PDFPhys Med Biol
October 2017
Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology, Im Neuenheimer Feld 400, Heidelberg, Germany.
Currently there is a rising interest in helium ion beams for radiotherapy. For benchmarking of the physical beam models used in treatment planning, there is a need for experimental data on the composition and spatial distribution of mixed ion fields. Of particular interest are the attenuation of the primary helium ion fluence and the build-up of secondary hydrogen ions due to nuclear interactions.
View Article and Find Full Text PDFPhys Med Biol
September 2017
Department of Medical Physics in Radiation Oncology, German Cancer Research Center-DKFZ, Im NeuenheimerFeld 280, D-69120 Heidelberg, Germany. Heidelberg Institute for Radiation Oncology-HIRO, Im Neuenheimer Feld 280, D-69120, Germany.
Radiation therapy treatment planning requires an incorporation of uncertainties in order to guarantee an adequate irradiation of the tumor volumes. In current clinical practice, uncertainties are accounted for implicitly with an expansion of the target volume according to generic margin recipes. Alternatively, it is possible to account for uncertainties by explicit minimization of objectives that describe worst-case treatment scenarios, the expectation value of the treatment or the coverage probability of the target volumes during treatment planning.
View Article and Find Full Text PDFPhys Med Biol
August 2017
Division of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), 69120 Heidelberg, Germany.
The aim of this work was to determine magnetic field correction factors that are needed for dosimetry in hybrid devices for MR-guided radiotherapy for Farmer-type ionization chambers for different magnetic field strengths and field orientations. The response of six custom-built Farmer-type chambers irradiated at a 6 MV linac was measured in a water tank positioned in a magnet with magnetic field strengths between 0.0 T and 1.
View Article and Find Full Text PDFPhys Med Biol
February 2017
Department of Radiation Oncology, Heidelberg University Clinic, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. National Center for Radiation Oncology (NCRO), 69120 Heidelberg, Germany. Heidelberg Institute for Radiation Oncology (HIRO), 69120 Heidelberg, Germany.
Afterloading brachytherapy is conducted by the stepwise movement of a radioactive source through surgically implanted applicator tubes where at predefined dwell positions calculated dwell times optimize spatial dose delivery with respect to a planned dose level. The temporal exposure pattern exhibits drastic fluctuations in dose rate at a given coordinate and within a single treatment session because of the discontinuous and repeated source movement into the target volume. This could potentially affect biological response.
View Article and Find Full Text PDF